Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study-Reference-Cited by-同舟云学术

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

Published:2018-05-31 Issue:5 Volume:30 Page:579-588
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Parker William A. E.¹^ORCID,Eriksson Niclas²,Becker Richard C.³,Voora Deepak⁴,Åkerblom Axel⁵,Himmelmann Anders⁶,James Stefan K.⁵,Wallentin Lars⁵,Storey Robert F.¹,

Affiliation:

1. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom

2. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

3. Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, University of Cincinnati College of Medicine, Cincinnati, OH, USA

4. Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA

5. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

6. AstraZeneca Research and Development, Gothenburg, Sweden

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2018.1478404

Reference29 articles.